Valeant Costs Hedge Funds $3 Billion as Ackman, Paulson Hit

  • Ackman loses $767 million, Paulson about $471 million
  • Stock sinks as forecast cut, company issues debt warning

Valeant Suffers Biggest Drop on Record, What's Next?

It’s another painful day for Valeant Pharmaceuticals International Inc. shareholders.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.